Individuals Stopping Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Than People Using Diet and Exercise

Fresh analysis suggests that people who discontinue new slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who end conventional lifestyle plans.

Published data in a major medical journal demonstrates that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"People purchasing these medications must be aware of the potential of quick weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.

Such speed of regain means a return to starting mass within about 18 months.

Weighing Approaches

The analysis, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with older methods.

Researchers point out that people who shed pounds through lifestyle changes alone usually have a slower weight regain—approximately 100 grams monthly—after stopping.

Understanding the Quick Rebound

Doctors propose the mechanism of the injections explains the accelerated regain.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement results in appetite is unsuppressed, making binge eating far more likely."

A Lifelong Condition?

The NHS advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the high risk of relapse, the therapy should be considered ongoing.

This perspective is echoed by pharmaceutical companies, who state that the results "emphasize the persistent nature of obesity," similar to managing diseases like diabetes.

Patient Testimonies

Individuals who have stopped the jabs explain a intense resurgence of hunger.

"I experienced a trigger flipping and I was suddenly ravenous," recalled an individual.

This challenge is compounded if patients have not established permanent lifestyle or habit changes during therapy.

Growing Interest

Survey data suggest that millions of people in the UK have used these injections in the past year, with desire continuing to grow.

• Use is more common among women than males.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Finally, researchers stress that while these medications are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits relies on integrated behavioural support.